Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Melanoma

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 147 articles: HTML format Text format

Single Articles

February 2010
1. SEEGER JM , Schmidt P, Brinkmann K, Hombach AA, et al
   The Proteasome Inhibitor Bortezomib Sensitizes Melanoma Cells toward Adoptive CTL Attack.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. JANE-VALBUENA J , Widlund HR, Perner S, Johnson LA, et al
   An Oncogenic Role for ETV1 in Melanoma.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
3. CONFORTI R , Ma Y, Morel Y, Paturel C, et al
   Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands.
   Cancer Res. 2010;70:490-500.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. DU W , Takuwa N, Yoshioka K, Okamoto Y, et al
   S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice.
   Cancer Res. 2010;70:772-81.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. SCHATTON T , Schutte U, Frank NY, Zhan Q, et al
   Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. WANG W , Niendorf KB, Patel D, Blackford A, et al
   Estimating CDKN2A Carrier Probability and Personalizing Cancer Risk Assessments in Hereditary Melanoma Using MelaPRO.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. CUI Y , Borysova MK, Johnson JO, Guadagno TM, et al
   Oncogenic B-RafV600E Induces Spindle Abnormalities, Supernumerary Centrosomes, and Aneuploidy in Human Melanocytic Cells.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. HELD MA , Curley DP, Dankort D, McMahon M, et al
   Characterization of melanoma cells capable of propagating tumors from a single cell.
   Cancer Res. 2010;70:388-97.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. KUMASAKA MY , Yajima I, Hossain K, Iida M, et al
   A novel mouse model for de novo Melanoma.
   Cancer Res. 2010;70:24-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
10. PUIG-KROGER A , Sierra-Filardi E, Dominguez-Soto A, Samaniego R, et al
    Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages.
    Cancer Res. 2009;69:9395-403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. UGEL S , Zoso A, De Santo C, Li Y, et al
    In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.
    Cancer Res. 2009;69:9376-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. COLIE S , Van Veldhoven PP, Kedjouar B, Bedia C, et al
    Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation.
    Cancer Res. 2009;69:9346-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. BOBISSE S , Rondina M, Merlo A, Tisato V, et al
    Reprogramming T Lymphocytes for Melanoma Adoptive Immunotherapy by T-Cell Receptor Gene Transfer with Lentiviral Vectors.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. CHO HI , Celis E
    Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects.
    Cancer Res. 2009;69:9012-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
15. VO DD , Prins RM, Begley JL, Donahue TR, et al
    Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.
    Cancer Res. 2009;69:8693-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. LIU JW , Sun P, Yan Q, Paller AS, et al
    De-N-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling-Dependent MMP-2 Activation.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. YANG G , Thieu K, Tsai KY, Piris A, et al
    Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
18. GALANZHA EI , Shashkov EV, Spring PM, Suen JY, et al
    In vivo, Noninvasive, Label-Free Detection and Eradication of Circulating Metastatic Melanoma Cells Using Two-Color Photoacoustic Flow Cytometry with a Diode Laser.
    Cancer Res. 2009;69:7926-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. PINNER S , Jordan P, Sharrock K, Bazley L, et al
    Intravital Imaging Reveals Transient Changes in Pigment Production and Brn2 Expression during Metastatic Melanoma Dissemination.
    Cancer Res. 2009;69:7969-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. JANDUS C , Bioley G, Dojcinovic D, Derre L, et al
    Tumor Antigen-Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. VAN STIPDONK MJ , Badia-Martinez D, Sluijter M, Offringa R, et al
    Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100.
    Cancer Res. 2009;69:7784-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
22. YOSHIMURA K , Meckel KF, Laird LS, Chia CY, et al
    Integrin alpha2 mediates selective metastasis to the liver.
    Cancer Res. 2009;69:7320-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. YANG J , Price MA, Li GY, Bar-Eli M, et al
    Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. HOLLESTELLE A , Schutte M
    Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. TANAKA H , Matsushima H, Nishibu A, Clausen BE, et al
    Dual therapeutic efficacy of vinblastine as a unique chemotherapeutic agent capable of inducing dendritic cell maturation.
    Cancer Res. 2009;69:6987-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
26. VILLARES GJ , Dobroff AS, Wang H, Zigler M, et al
    Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.
    Cancer Res. 2009;69:6730-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. KHODADOUST MS , Verhaegen M, Kappes F, Riveiro-Falkenbach E, et al
    Melanoma proliferation and chemoresistance controlled by the DEK oncogene.
    Cancer Res. 2009;69:6405-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. HIMOUDI N , Yan M, Bouma G, Morgenstern D, et al
    Migratory and antigen presentation functions of IFN-producing killer dendritic cells.
    Cancer Res. 2009;69:6598-606.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. NORELL H , Martins da Palma T, Lesher A, Kaur N, et al
    Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27-35)-reactive T cells from activation-induced cell death.
    Cancer Res. 2009;69:6282-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
30. WELSH MM , Applebaum KM, Spencer SK, Perry AE, et al
    CTLA4 Variants, UV-Induced Tolerance, and Risk of Non-Melanoma Skin Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. KOHLMEYER J , Cron M, Landsberg J, Bald T, et al
    Complete Regression of Advanced Primary and Metastatic Mouse Melanomas following Combination Chemoimmunotherapy.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. CULLEN M , Seaman S, Chaudhary A, Yang MY, et al
    Host-Derived Tumor Endothelial Marker 8 Promotes the Growth of Melanoma.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. HAUSNER SH , Abbey CK, Bold RJ, Gagnon MK, et al
    Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model.
    Cancer Res. 2009;69:5843-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. MENG X , Leyva ML, Jenny M, Gross I, et al
    A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOP.
    Cancer Res. 2009;69:5458-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
35. CHAMBERS AF
    MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. PINNIX CC , Lee JT, Liu ZJ, McDaid R, et al
    Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
37. ZHAO X , Graves C, Ames SJ, Fisher DE, et al
    Mechanism of Regulation and Suppression of Melanoma Invasiveness by Novel Retinoic Acid Receptor-{gamma} Target Gene Carbohydrate Sulfotransferase 10.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. HONG C , Lee H, Park YK, Shin J, et al
    Regulation of secondary antigen-specific CD8(+) T-cell responses by natural killer T cells.
    Cancer Res. 2009;69:4301-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. FRANCOIS V , Ottaviani S, Renkvist N, Stockis J, et al
    The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. DONG X , Mattingly CA, Tseng MT, Cho MJ, et al
    Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.
    Cancer Res. 2009;69:3918-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. GRINSHTEIN N , Bridle B, Wan Y, Bramson JL, et al
    Neoadjuvant vaccination provides superior protection against tumor relapse following surgery compared with adjuvant vaccination.
    Cancer Res. 2009;69:3979-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
42. CEDERVALL J , Jamil S, Prasmickaite L, Cheng Y, et al
    Species-Specific In vivo Engraftment of the Human BL Melanoma Cell Line Results in an Invasive Dedifferentiated Phenotype Not Present in Xenografts.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. TOYOOKA T , Ibuki Y
    Histone deacetylase inhibitor sodium butyrate enhances the cell killing effect of psoralen plus UVA by attenuating nucleotide excision repair.
    Cancer Res. 2009;69:3492-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. DUAN F , Lin Y, Liu C, Engelhorn ME, et al
    Immune rejection of mouse tumors expressing mutated self.
    Cancer Res. 2009;69:3545-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. IVANOV VN , Zhou H, Partridge MA, Hei TK, et al
    Inhibition of Ataxia Telangiectasia Mutated Kinase Activity Enhances TRAIL-Mediated Apoptosis in Human Melanoma Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. SMALLEY KS , Nathanson KL, Flaherty KT
    Genetic Subgrouping of Melanoma Reveals New Opportunities for Targeted Therapy.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. LAHDENRANTA J , Hagendoorn J, Padera TP, Hoshida T, et al
    Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis.
    Cancer Res. 2009;69:2801-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. PAVELKO KD , Hansen MJ, Pease LR
    CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejection.
    Cancer Res. 2009;69:3114-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. ULUCKAN O , Becker SN, Deng H, Zou W, et al
    CD47 regulates bone mass and tumor metastasis to bone.
    Cancer Res. 2009;69:3196-204.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. HOEFLICH KP , Herter S, Tien J, Wong L, et al
    Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression.
    Cancer Res. 2009;69:3042-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. LONG CM , van Laarhoven HW, Bulte JW, Levitsky HI, et al
    Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes.
    Cancer Res. 2009;69:3180-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
52. SCHUURHUIS DH , Verdijk P, Schreibelt G, Aarntzen EH, et al
    In situ Expression of Tumor Antigens by Messenger RNA-Electroporated Dendritic Cells in Lymph Nodes of Melanoma Patients.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. HARLIN H , Meng Y, Peterson AC, Zha Y, et al
    Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. BAILET O , Fenouille N, Abbe P, Robert G, et al
    Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. ROBEY IF , Baggett BK, Kirkpatrick ND, Roe DJ, et al
    Bicarbonate increases tumor pH and inhibits spontaneous metastases.
    Cancer Res. 2009;69:2260-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. MURALIDHARAN-CHARI V , Hoover H, Clancy J, Schweitzer J, et al
    ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo.
    Cancer Res. 2009;69:2201-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. KORTYLEWSKI M , Kujawski M, Herrmann A, Yang C, et al
    Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy.
    Cancer Res. 2009;69:2497-505.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. SOBOLEV O , Stern P, Lacy-Hulbert A, Hynes RO, et al
    Natural killer cells require selectins for suppression of subcutaneous tumors.
    Cancer Res. 2009;69:2531-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. YAMAURA M , Mitsushita J, Furuta S, Kiniwa Y, et al
    NADPH Oxidase 4 Contributes to Transformation Phenotype of Melanoma Cells by Regulating G2-M Cell Cycle Progression.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. SHURIN MR , Potapovich AI, Tyurina YY, Tourkova IL, et al
    Recognition of Live Phosphatidylserine-Labeled Tumor Cells by Dendritic Cells: A Novel Approach to Immunotherapy of Skin Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
61. PARRI M , Taddei ML, Bianchini F, Calorini L, et al
    EphA2 Reexpression Prompts Invasion of Melanoma Cells Shifting from Mesenchymal to Amoeboid-like Motility Style.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. KLEIN RM , Aplin AE
    Rnd3 Regulation of the Actin Cytoskeleton Promotes Melanoma Migration and Invasive Outgrowth in Three Dimensions.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. VANBROCKLIN MW , Verhaegen M, Soengas MS, Holmen SL, et al
    Mitogen-Activated Protein Kinase Inhibition Induces Translocation of Bmf to Promote Apoptosis in Melanoma.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. NASARRE P , Thomas M, Kruse K, Helfrich I, et al
    Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth.
    Cancer Res. 2009;69:1324-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. INUZUKA T , Tsuda M, Tanaka S, Kawaguchi H, et al
    Integral role of transcription factor 8 in the negative regulation of tumor angiogenesis.
    Cancer Res. 2009;69:1678-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. LISSITZKY JC , Parriaux D, Ristorcelli E, Verine A, et al
    Cyclic AMP Signaling as a Mediator of Vasculogenic Mimicry in Aggressive Human Melanoma Cells In vitro.
    Cancer Res. 2009;69:802-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. EBERT LM , Liu YC, Clements CS, Robson NC, et al
    A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.
    Cancer Res. 2009;69:1046-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. XIE T , Nguyen T, Hupe M, Wei ML, et al
    Multidrug resistance decreases with mutations of melanosomal regulatory genes.
    Cancer Res. 2009;69:992-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
69. HOFFMAN RM
    Comment re: Preclinical model of spontaneous melanoma metastasis.
    Cancer Res. 2009;69:719.
    PubMed     Text format     Related articles   
    
    
    
70. APRELIKOVA O , Pandolfi S, Tackett S, Ferreira M, et al
    Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.
    Cancer Res. 2009;69:616-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. ZHENG H , Gao L, Feng Y, Yuan L, et al
    Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration.
    Cancer Res. 2009;69:449-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. SINGH S , Varney M, Singh RK
    Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis.
    Cancer Res. 2009;69:411-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. HE H , Nagy R, Liyanarachchi S, Jiao H, et al
    A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24.
    Cancer Res. 2009;69:625-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. ZHANG C , Zhang F, Tsan R, Fidler IJ, et al
    Transforming Growth Factor-{beta}2 Is a Molecular Determinant for Site-Specific Melanoma Metastasis in the Brain.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. ANDERBERG C , Li H, Fredriksson L, Andrae J, et al
    Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts.
    Cancer Res. 2009;69:369-78.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. LI B , Vincent A, Cates J, Brantley-Sieders DM, et al
    Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site.
    Cancer Res. 2009;69:338-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
77. SOLOMON DA , Kim JS, Cronin JC, Sibenaller Z, et al
    Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.
    Cancer Res. 2008;68:10300-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. DISSANAYAKE SK , Olkhanud PB, O'Connell MP, Carter A, et al
    Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.
    Cancer Res. 2008;68:10205-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. SAENGER YM , Li Y, Chiou KC, Chan B, et al
    Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
    Cancer Res. 2008;68:9884-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. HAMAI A , Meslin F, Benlalam H, Jalil A, et al
    ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway.
    Cancer Res. 2008;68:9854-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. HUANG FJ , Steeg PS, Price JE, Chiu WT, et al
    Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.
    Cancer Res. 2008;68:9634-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. ASSUDANI D , Cho HI, DeVito N, Bradley N, et al
    In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells.
    Cancer Res. 2008;68:9892-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. SETIADI AF , Omilusik K, David MD, Seipp RP, et al
    Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors.
    Cancer Res. 2008;68:9601-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
84. UMANSKY V , Abschuetz O, Osen W, Ramacher M, et al
    Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors.
    Cancer Res. 2008;68:9451-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. MINKIS K , Kavanagh DG, Alter G, Bogunovic D, et al
    Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.
    Cancer Res. 2008;68:9441-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. VILLARES GJ , Zigler M, Wang H, Melnikova VO, et al
    Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.
    Cancer Res. 2008;68:9078-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. JINUSHI M , Nakazaki Y, Carrasco DR, Draganov D, et al
    Milk Fat Globule EGF-8 Promotes Melanoma Progression through Coordinated Akt and Twist Signaling in the Tumor Microenvironment.
    Cancer Res. 2008;68:8889-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
88. STAQUICINI FI , Tandle A, Libutti SK, Sun J, et al
    A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans.
    Cancer Res. 2008;68:8419-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. LESINSKI GB , Raig ET, Guenterberg K, Brown L, et al
    IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosis.
    Cancer Res. 2008;68:8351-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. BANIHASHEMI B , Vlad R, Debeljevic B, Giles A, et al
    Ultrasound imaging of apoptosis in tumor response: novel preclinical monitoring of photodynamic therapy effects.
    Cancer Res. 2008;68:8590-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. TARANOVA AG , Maldonado D 3rd, Vachon CM, Jacobsen EA, et al
    Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung.
    Cancer Res. 2008;68:8582-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. SCHULER P , Contassot E, Irla M, Hugues S, et al
    Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells.
    Cancer Res. 2008;68:8410-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. BARTOLOME RA , Wright N, Molina-Ortiz I, Sanchez-Luque FJ, et al
    Activated G(alpha)13 impairs cell invasiveness through p190RhoGAP-mediated inhibition of RhoA activity.
    Cancer Res. 2008;68:8221-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. LIU W , Cheng S, Asa SL, Ezzat S, et al
    The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.
    Cancer Res. 2008;68:8104-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. MACIAG PC , Seavey MM, Pan ZK, Ferrone S, et al
    Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.
    Cancer Res. 2008;68:8066-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. JAKSCH M , Munera J, Bajpai R, Terskikh A, et al
    Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines.
    Cancer Res. 2008;68:7882-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. RODRIGUEZ M , Aladowicz E, Lanfrancone L, Goding CR, et al
    Tbx3 represses e-cadherin expression and enhances melanoma invasiveness.
    Cancer Res. 2008;68:7872-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. GOODALL J , Carreira S, Denat L, Kobi D, et al
    Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
    Cancer Res. 2008;68:7788-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
99. TRAN MA , Gowda R, Sharma A, Park EJ, et al
    Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.
    Cancer Res. 2008;68:7638-49.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. KWON M , Hanna E, Lorang D, He M, et al
     Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.
     Cancer Res. 2008;68:7332-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. KIM YH , Choi BK, Kim KH, Kang SW, et al
     Combination therapy with cisplatin and anti-4-1BB: synergistic anticancer effects and amelioration of cisplatin-induced nephrotoxicity.
     Cancer Res. 2008;68:7264-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. LEBEDEVA IV , Su ZZ, Vozhilla N, Chatman L, et al
     Mechanism of In vitro Pancreatic Cancer Cell Growth Inhibition by Melanoma Differentiation-Associated Gene-7/Interleukin-24 and Perillyl Alcohol.
     Cancer Res. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
103. JIANG CC , Lucas K, Avery-Kiejda KA, Wade M, et al
     Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress.
     Cancer Res. 2008;68:6708-17.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. HO-TIN-NOE B , Goerge T, Cifuni SM, Duerschmied D, et al
     Platelet granule secretion continuously prevents intratumor hemorrhage.
     Cancer Res. 2008;68:6851-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. KLECHEVSKY E , Gallegos M, Denkberg G, Palucka K, et al
     Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts.
     Cancer Res. 2008;68:6360-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. MA Y , Kurtyka CA, Boyapalle S, Sung SS, et al
     A small-molecule E2F inhibitor blocks growth in a melanoma culture model.
     Cancer Res. 2008;68:6292-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
107. INOUE-NARITA T , Hamada K, Sasaki T, Hatakeyama S, et al
     Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis.
     Cancer Res. 2008;68:5760-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. SMALLEY KS , Contractor R, Nguyen TK, Xiao M, et al
     Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression.
     Cancer Res. 2008;68:5743-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. LOVAT PE , Corazzari M, Armstrong JL, Martin S, et al
     Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress.
     Cancer Res. 2008;68:5363-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. GIAMMARIOLI AM , Maselli A, Casagrande A, Gambardella L, et al
     Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism.
     Cancer Res. 2008;68:5291-300.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. NIERKENS S , den Brok MH, Sutmuller RP, Grauer OM, et al
     In vivo colocalization of antigen and cytidyl guanosyl within dendritic cells is associated with the efficacy of cancer immunotherapy.
     Cancer Res. 2008;68:5390-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
112. MONTAGUT C , Sharma SV, Shioda T, McDermott U, et al
     Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma.
     Cancer Res. 2008;68:4853-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. CRUZ-MUNOZ W , Man S, Xu P, Kerbel RS, et al
     Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
     Cancer Res. 2008;68:4500-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. ELIOPOULOS N , Francois M, Boivin MN, Martineau D, et al
     Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy.
     Cancer Res. 2008;68:4810-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. MOLHOEK KR , Griesemann H, Shu J, Gershenwald JE, et al
     Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.
     Cancer Res. 2008;68:4392-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. LO RS , Witte ON
     Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytes.
     Cancer Res. 2008;68:4248-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
117. CONNEROTTE T , Van Pel A, Godelaine D, Tartour E, et al
     Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities.
     Cancer Res. 2008;68:3931-3940.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. AUGUSTINE CK , Yoshimoto Y, Gupta M, Zipfel PA, et al
     Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment.
     Cancer Res. 2008;68:3777-84.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. VAN KILSDONK JW , Wilting RH, Bergers M, van Muijen GN, et al
     Attenuation of Melanoma Invasion by a Secreted Variant of Activated Leukocyte Cell Adhesion Molecule.
     Cancer Res. 2008;68:3671-3679.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. COE BP , Macaulay C, Lam WL, Ylstra B, et al
     Comment re: a comparison of DNA copy number profiling platforms.
     Cancer Res. 2008;68:4010.
     PubMed     Text format     Related articles   
     
     
     
121. HOSOI A , Takeda Y, Furuichi Y, Kurachi M, et al
     Memory Th1 cells augment tumor-specific CTL following transcutaneous peptide immunization.
     Cancer Res. 2008;68:3941-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. CHEUNG M , Sharma A, Madhunapantula SV, Robertson GP, et al
     Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.
     Cancer Res. 2008;68:3429-39.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. DYNEK JN , Chan SM, Liu J, Zha J, et al
     Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
     Cancer Res. 2008;68:3124-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. GOLDBERGER O , Volovitz I, Machlenkin A, Vadai E, et al
     Exuberated numbers of tumor-specific T cells result in tumor escape.
     Cancer Res. 2008;68:3450-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2008
125. FELICETTI F , Errico MC, Bottero L, Segnalini P, et al
     The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.
     Cancer Res. 2008;68:2745-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. SMYTH MJ , Teng MW, Sharkey J, Westwood JA, et al
     Interleukin 21 enhances antibody-mediated tumor rejection.
     Cancer Res. 2008;68:3019-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. EBERT LM , Tan BS, Browning J, Svobodova S, et al
     The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.
     Cancer Res. 2008;68:3001-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. EPARDAUD M , Elpek KG, Rubinstein MP, Yonekura AR, et al
     Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells.
     Cancer Res. 2008;68:2972-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. WAIBEL R , Treichler H, Schaefer NG, van Staveren DR, et al
     New derivatives of vitamin B12 show preferential targeting of tumors.
     Cancer Res. 2008;68:2904-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. GUTIERREZ-FERNANDEZ A , Fueyo A, Folgueras AR, Garabaya C, et al
     Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion.
     Cancer Res. 2008;68:2755-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. PAVELKO KD , Heckman KL, Hansen MJ, Pease LR, et al
     An effective vaccine strategy protective against antigenically distinct tumor variants.
     Cancer Res. 2008;68:2471-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. JORRITSMA A , Bins AD, Schumacher TN, Haanen JB, et al
     Skewing the T-cell repertoire by combined DNA vaccination, host conditioning, and adoptive transfer.
     Cancer Res. 2008;68:2455-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2008
133. POS Z , Wiener Z, Pocza P, Racz M, et al
     Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma.
     Cancer Res. 2008;68:1997-2005.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. MACHLENKIN A , Uzana R, Frankenburg S, Eisenberg G, et al
     Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs.
     Cancer Res. 2008;68:2006-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. ZHANG G , Njauw CN, Park JM, Naruse C, et al
     EphA2 is an essential mediator of UV radiation-induced apoptosis.
     Cancer Res. 2008;68:1691-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. JU T , Lanneau GS, Gautam T, Wang Y, et al
     Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.
     Cancer Res. 2008;68:1636-46.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. COTE AL , Usherwood EJ, Turk MJ
     Tumor-specific T-cell memory: clearing the regulatory T-cell hurdle.
     Cancer Res. 2008;68:1614-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. BEMIS LT , Chen R, Amato CM, Classen EH, et al
     MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.
     Cancer Res. 2008;68:1362-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. SINI P , Samarzija I, Baffert F, Littlewood-Evans A, et al
     Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics.
     Cancer Res. 2008;68:1581-92.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2008
140. CRIPPA L , Gasparri A, Sacchi A, Ferrero E, et al
     Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
     Cancer Res. 2008;68:1154-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. CHEN LH , Jiang CC, Watts R, Thorne RF, et al
     Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein.
     Cancer Res. 2008;68:834-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. VALLACCHI V , Daniotti M, Ratti F, Di Stasi D, et al
     CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.
     Cancer Res. 2008;68:715-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. LIN WM , Baker AC, Beroukhim R, Winckler W, et al
     Modeling genomic diversity and tumor dependency in malignant melanoma.
     Cancer Res. 2008;68:664-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. HOEK KS , Eichhoff OM, Schlegel NC, Dobbeling U, et al
     In vivo switching of human melanoma cells between proliferative and invasive states.
     Cancer Res. 2008;68:650-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2007
145. SOLIT DB , Santos E, Pratilas CA, Lobo J, et al
     3'-deoxy-3'-[18F]fluorothymidine positron emission tomography is a sensitive method for imaging the response of BRAF-dependent tumors to MEK inhibition.
     Cancer Res. 2007;67:11463-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. SHEN L , Kondo Y, Ahmed S, Boumber Y, et al
     Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel.
     Cancer Res. 2007;67:11335-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. SEBESTYEN Z , de Vrij J, Magnusson M, Debets R, et al
     An oncolytic adenovirus redirected with a tumor-specific T-cell receptor.
     Cancer Res. 2007;67:11309-16.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: